224 related articles for article (PubMed ID: 7536440)
1. Only late, nonmitotic stages of granulocyte differentiation in 32Dcl3 cells are blocked by ectopic expression of murine c-myb and its truncated forms.
Bies J; Mukhopadhyaya R; Pierce J; Wolff L
Cell Growth Differ; 1995 Jan; 6(1):59-68. PubMed ID: 7536440
[TBL] [Abstract][Full Text] [Related]
2. B-myb alters the response of myeloid precursor cells to G-CSF.
Engelhard A; Campbell K; Calabretta B
Exp Cell Res; 2000 Jan; 254(1):153-62. PubMed ID: 10623475
[TBL] [Abstract][Full Text] [Related]
3. Transcriptional activation potential of normal and tumor-associated myb isoforms does not correlate with their ability to block GCSF-induced terminal differentiation of murine myeloid precursor cells.
Patel G; Tantravahi R; Oh IH; Reddy EP
Oncogene; 1996 Sep; 13(6):1197-208. PubMed ID: 8808694
[TBL] [Abstract][Full Text] [Related]
4. Inactivation of a c-Myb/estrogen receptor fusion protein in transformed primary cells leads to granulocyte/macrophage differentiation and down regulation of c-kit but not c-myc or cdc2.
Hogg A; Schirm S; Nakagoshi H; Bartley P; Ishii S; Bishop JM; Gonda TJ
Oncogene; 1997 Dec; 15(24):2885-98. PubMed ID: 9416832
[TBL] [Abstract][Full Text] [Related]
5. Redundant functions of B-Myb and c-Myb in differentiating myeloid cells.
Golay J; Broccoli V; Borleri GM; Erba E; Faretta M; Basilico L; Ying GG; Piccinini G; Shapiro LH; Lovrić J; Nawrath M; Mölling K; Rambaldi A; Introna M
Cell Growth Differ; 1997 Dec; 8(12):1305-16. PubMed ID: 9419419
[TBL] [Abstract][Full Text] [Related]
6. Retroviral insertional activation of the EVI1 oncogene does not prevent G-CSF-induced maturation of the murine pluripotent myeloid cell line 32Dcl3.
Khanna-Gupta A; Lopingco MC; Savinelli T; Zibello T; Berliner N; Perkins AS
Oncogene; 1996 Feb; 12(3):563-9. PubMed ID: 8637713
[TBL] [Abstract][Full Text] [Related]
7. p21Waf1 inhibits granulocytic differentiation of 32Dcl3 cells.
Ghanem L; Steinman RA
Leuk Res; 2006 Oct; 30(10):1285-92. PubMed ID: 16499966
[TBL] [Abstract][Full Text] [Related]
8. Cytokine-dependent granulocytic differentiation. Regulation of proliferative and differentiative responses in a murine progenitor cell line.
Valtieri M; Tweardy DJ; Caracciolo D; Johnson K; Mavilio F; Altmann S; Santoli D; Rovera G
J Immunol; 1987 Jun; 138(11):3829-35. PubMed ID: 2438328
[TBL] [Abstract][Full Text] [Related]
9. The Gag-Myb-Ets fusion oncogene alters the apoptotic response and growth factor dependence of interleukin-3 dependent murine cells.
Athanasiou M; Mavrothalassitis GJ; Yuan CC; Blair DG
Oncogene; 1996 Jan; 12(2):337-44. PubMed ID: 8570210
[TBL] [Abstract][Full Text] [Related]
10. Differentiation primary response genes and proto-oncogenes as positive and negative regulators of terminal hematopoietic cell differentiation.
Liebermann DA; Hoffman B
Stem Cells; 1994 Jul; 12(4):352-69. PubMed ID: 7951003
[TBL] [Abstract][Full Text] [Related]
11. Induction of B cell lymphomas by overexpression of a Myb oncogene truncated at either terminus.
Press RD; Wisner TW; Ewert DL
Oncogene; 1995 Aug; 11(3):525-35. PubMed ID: 7630637
[TBL] [Abstract][Full Text] [Related]
12. Alteration of growth and differentiation factors response by Kirsten and Harvey sarcoma viruses in the IL-3-dependent murine hematopoietic cell line 32D C13(G).
Mavilio F; Kreider BL; Valtieri M; Naso G; Shirsat N; Venturelli D; Reddy EP; Rovera G
Oncogene; 1989 Mar; 4(3):301-8. PubMed ID: 2468124
[TBL] [Abstract][Full Text] [Related]
13. The induction of Friend erythroleukaemia differentiation is markedly affected by expression of a transfected c-myb cDNA.
McMahon J; Howe KM; Watson RJ
Oncogene; 1988 Dec; 3(6):717-20. PubMed ID: 2577875
[TBL] [Abstract][Full Text] [Related]
14. The C-terminal cytoplasmic region of the granulocyte colony-stimulating factor receptor mediates apoptosis in maturation-incompetent murine myeloid cells.
Dong F; Pouwels K; Hoefsloot LH; Rozemuller H; Löwenberg B; Touw IP
Exp Hematol; 1996 Feb; 24(2):214-20. PubMed ID: 8641344
[TBL] [Abstract][Full Text] [Related]
15. Nitric oxide-releasing agents and cGMP analogues inhibit murine erythroleukemia cell differentiation and suppress erythroid-specific gene expression: correlation with decreased DNA binding of NF-E2 and altered c-myb mRNA expression.
Suhasini M; Boss GR; Pascual FE; Pilz RB
Cell Growth Differ; 1995 Dec; 6(12):1559-66. PubMed ID: 9019161
[TBL] [Abstract][Full Text] [Related]
16. Oncogenic activation of c-Myb by carboxyl-terminal truncation leads to decreased proteolysis by the ubiquitin-26S proteasome pathway.
Bies J; Wolff L
Oncogene; 1997 Jan; 14(2):203-12. PubMed ID: 9010222
[TBL] [Abstract][Full Text] [Related]
17. MuLV-insertional mutagenesis of c-myb and Mml1 in a murine model for promonocytic leukemia.
Bies J; Koller R; Hoffman B; Amanullah A; Mock B; Wolff L
Leukemia; 1997 Apr; 11 Suppl 3():247-50. PubMed ID: 9209355
[TBL] [Abstract][Full Text] [Related]
18. Differentiation induced by the c-Mpl cytokine receptor is blocked by mutant Shc adaptor protein.
Hill RJ; Zozulya S; Lu YL; Hollenbach PW; Joyce-Shaikh B; Bogenberger J; Gishizky ML
Cell Growth Differ; 1996 Sep; 7(9):1125-34. PubMed ID: 8877093
[TBL] [Abstract][Full Text] [Related]
19. Regulation of cell proliferation: late down-regulation of c-myb preceding myelo-monocytic cell differentiation.
Yen A; Samuel V; Forbes M
J Cell Physiol; 1992 Oct; 153(1):147-56. PubMed ID: 1522128
[TBL] [Abstract][Full Text] [Related]
20. The v-src oncogene blocks the differentiation of a murine myeloid progenitor cell line and induces a tumorigenic phenotype.
Krüger A; Anderson SM
Oncogene; 1991 Feb; 6(2):245-56. PubMed ID: 1705687
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
